Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

462
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
462

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Assessing Patient Awareness and Misconceptions Regarding MRI Radiation Risks in China: A Questionnaire Study.

Nursing open·2026
Same author

ROS-Activatable "off-on" Fluorescent Prodrug Loaded Micelles for Targeted Therapy and in Situ Imaging of Breast Cancer Cells.

International journal of pharmaceutics: X·2026
Same author

Effectiveness of a chronic care model-based transitional care program for patients with biliary drainage: a randomized controlled trial.

Annals of medicine and surgery (2012)·2026
Same author

Responses of soil microbial community diversity to thinning and replanting, and their effects on microbial necromass carbon accumulation efficiency.

Frontiers in microbiology·2026
Same author

Differential roles of alexithymia components in linking autistic traits to personal distress and empathy concern.

Frontiers in psychology·2026
Same author

Lasiokaurin suppresses hepatocellular carcinoma proliferation and induces apoptosis via the JAK2/STAT3 pathway.

Journal of molecular histology·2026

相关实验视频

Updated: May 25, 2025

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

6.1K

HDAC3:免疫疗法敏感化中的多面调节器

Rui Han1,2, Yujun Luo1,2, Jingdong Gao1,2,3

  • 1Oncology Department of Chinese Medicine, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, China.

Vaccines
|February 26, 2025
PubMed
概括

基斯脱乙酶3 (HDAC3) 重塑瘤免疫微环境,使冷瘤变得热. HDAC3 抑制剂提供了一种有前途的策略,以提高癌症免疫疗法的疗效和患者的治疗结果.

关键词:
在 HDAC3 中,HDAC3 是组合疗法治疗组合治疗.免疫调节的免疫调节瘤免疫疗法 免疫疗法瘤微环境是一个微环境.

更多相关视频

Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

6.5K
Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

9.7K

相关实验视频

Last Updated: May 25, 2025

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

6.1K
Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

6.5K
Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

9.7K

科学领域:

  • 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
  • 癌症免疫学 癌症免疫学
  • 免疫治疗是一种免疫疗法.

背景情况:

  • 基因组脱乙酶3 (HDAC3) 是癌症中的一个关键的表观遗传调节剂.
  • HDAC3影响瘤的进展和免疫细胞的功能.
  • 准HDAC3为癌症免疫治疗提供了一个新的策略.

研究的目的:

  • 为了全面探索HDAC3在癌症中的多方面的作用.
  • 为了研究HDAC3对免疫调节通路的调节.
  • 检查HDAC3对各种免疫细胞类型和瘤免疫微环境的影响.

主要方法:

  • 探索HDAC3对cGAS-STING,铁和Nrf2/HO-1通路的调节.
  • 分析HDAC3对T细胞,NK细胞,树突细胞和巨细胞的影响.
  • 审查涉及HDAC3抑制剂的治疗策略.

主要成果:

  • HDAC3调节关键的免疫通路,对抗瘤免疫至关重要.
  • HDAC3增强免疫细胞功能,包括T细胞激活和NK细胞细胞毒性.
  • HDAC3将免疫学上"冷"的瘤转化为"热"的瘤,改善免疫疗法反应.

结论:

  • 抑制HDAC3是癌症免疫治疗的一个有前途的治疗策略.
  • HDAC3 抑制剂可以单独使用或与其他治疗结合使用,以克服耐药性.
  • 选择性抑制剂和先进的输送系统等创新策略可以提高HDAC3向治疗的疗效和安全性.